Design Therapeutics, Inc. (DSGN) on GreekSoup https://greeksoup.ai/stocks/us/dsgn/ Every dated entry in the public record on Design Therapeutics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 30 Oct 2026 00:00:00 +0000 Design Therapeutics, Inc.: short interest 6,653,634 shares at the 15 October 2026 settlement, 11.99 days to coverhttps://greeksoup.ai/stocks/us/dsgn/short-interest/us:DSGN:short-interest:2026-10-15:25d1ae5d1fThu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Design Therapeutics, Inc.: short interest 6,616,513 shares at the 30 September 2026 settlement, 8.69 days to coverhttps://greeksoup.ai/stocks/us/dsgn/short-interest/us:DSGN:short-interest:2026-09-30:067030348cWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Design Therapeutics, Inc.: short interest 5,461,508 shares at the 15 September 2026 settlement, 7.26 days to coverhttps://greeksoup.ai/stocks/us/dsgn/short-interest/us:DSGN:short-interest:2026-09-15:90d5fdb597Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Design Therapeutics, Inc.: short interest 5,542,463 shares at the 31 August 2026 settlement, 8.98 days to coverhttps://greeksoup.ai/stocks/us/dsgn/short-interest/us:DSGN:short-interest:2026-08-31:2b7a978043Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Design Therapeutics, Inc.: Schedule 13G/A filed by Point72 Asset Management, L.P., 3.8% of the classhttps://greeksoup.ai/stocks/us/dsgn/holders/us:DSGN:schedule-13:2026-08-14:e4fdcae1e0Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Design Therapeutics, Inc.: Schedule 13G filed by Sirenia Capital Management LP, 9.5% of the classhttps://greeksoup.ai/stocks/us/dsgn/holders/us:DSGN:schedule-13:2026-08-14:d01ff06ce3Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Design Therapeutics, Inc.: short interest 5,925,557 shares at the 14 August 2026 settlement, 15.23 days to coverhttps://greeksoup.ai/stocks/us/dsgn/short-interest/us:DSGN:short-interest:2026-08-14:e4981f76faFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Design Therapeutics, Inc. Q2 FY2026 results: revenue $0, net income -$20 millionhttps://greeksoup.ai/stocks/us/dsgn/results/fy2026-q2/us:DSGN:result:2026-08-03:bde0355997Mon, 03 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Design Therapeutics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/dsgn/filings/us:DSGN:filing:2026-08-03:dce28a99f1Mon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Design Therapeutics, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/dsgn/filings/us:DSGN:filing:2026-08-03:62e34bec98Mon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>